Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 231127

1.

Focused antibody response to influenza linked to antigenic drift.

Huang KY, Rijal P, Schimanski L, Powell TJ, Lin TY, McCauley JW, Daniels RS, Townsend AR.

J Clin Invest. 2015 May 26. pii: 81104. doi: 10.1172/JCI81104. [Epub ahead of print]

PMID:
26011643
2.

Novel monoclonal antibodies that recognize both rat and mouse phosphatidylserine/prothrombin complexes.

Kawakami T, Yoon SY, Takeuchi S, Soma Y, Kuroha S, Yoshida S, Shida H, Nakazawa D, Tomaru U, Ishizu A.

Mod Rheumatol. 2015 May 26:1-9. [Epub ahead of print] No abstract available.

PMID:
26011442
3.

Moss-made pharmaceuticals: from bench to bedside.

Reski R, Parsons J, Decker EL.

Plant Biotechnol J. 2015 May 25. doi: 10.1111/pbi.12401. [Epub ahead of print]

PMID:
26011014
4.

Selective neutralization of the serpin protease nexin-1 by a specific monoclonal antibody.

François D, Venisse L, Brouwers E, Arocas V, Declerck P, Bouton MC.

Br J Haematol. 2015 May 26. doi: 10.1111/bjh.13522. [Epub ahead of print] No abstract available.

PMID:
26010932
5.

Host cell proteins in biotechnology-derived products: A risk assessment framework.

de Zafra CL, Quarmby V, Francissen K, Vanderlaan M, Zhu-Shimoni J.

Biotechnol Bioeng. 2015 May 25. doi: 10.1002/bit.25647. [Epub ahead of print]

PMID:
26010760
6.

Exploring the Feasibility of Multi-Site Flow Cytometric Processing of Gut Associated Lymphoid Tissue with Centralized Data Analysis for Multi-Site Clinical Trials.

McGowan I, Anton PA, Elliott J, Cranston RD, Duffill K, Althouse AD, Hawkins KL, De Rosa SC.

PLoS One. 2015 May 26;10(5):e0126454. doi: 10.1371/journal.pone.0126454. eCollection 2015.

7.

Selective Oxidation of Methionine and Tryptophan Residues in a Therapeutic IgG1 Molecule.

Folzer E, Diepold K, Bomans K, Finkler C, Schmidt R, Bulau P, Huwyler J, Mahler HC, Koulov AV.

J Pharm Sci. 2015 May 25. doi: 10.1002/jps.24509. [Epub ahead of print]

PMID:
26010344
8.

Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection.

Sheehan KC, Lazear HM, Diamond MS, Schreiber RD.

PLoS One. 2015 May 26;10(5):e0128636. doi: 10.1371/journal.pone.0128636. eCollection 2015.

9.

A novel immunoassay to measure total serum lymphotoxin α levels in the presence of an anti-LTα therapeutic antibody.

Young J, Nguyen A, Qiu ZJ, Ying Y, Gao X, Reed C, Chuntharapai A, Deng R, Lutman J, Grogan J, Wong WL, DeForge L.

J Immunol Methods. 2015 May 22. pii: S0022-1759(15)00163-5. doi: 10.1016/j.jim.2015.05.006. [Epub ahead of print]

PMID:
26009247
10.

Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy.

Moles E, Urbán P, Jiménez-Díaz MB, Viera-Morilla S, Angulo-Barturen I, Busquets MA, Fernàndez-Busquets X.

J Control Release. 2015 May 22. pii: S0168-3659(15)00583-0. doi: 10.1016/j.jconrel.2015.05.284. [Epub ahead of print]

PMID:
26008752
11.

A Highly Sensitive Porous Silicon (P-Si)-Based Human Kallikrein 2 (hK2) Immunoassay Platform toward Accurate Diagnosis of Prostate Cancer.

Lee SW, Hosokawa K, Kim S, Jeong OC, Lilja H, Laurell T, Maeda M.

Sensors (Basel). 2015 May 22;15(5):11972-87. doi: 10.3390/s150511972.

12.

Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment.

Levay A, Brenneman R, Hoinka J, Sant D, Cardone M, Trinchieri G, Przytycka TM, Berezhnoy A.

Nucleic Acids Res. 2015 May 24. pii: gkv534. [Epub ahead of print]

13.

Encapsulated Cellular Implants for Recombinant Protein Delivery and Therapeutic Modulation of the Immune System.

Lathuilière A, Mach N, Schneider BL.

Int J Mol Sci. 2015 May 8;16(5):10578-10600. Review.

14.
15.

Profile of elotuzumab and its potential in the treatment of multiple myeloma.

Liu YC, Szmania S, van Rhee F.

Blood Lymphat Cancer. 2014 Jun;2014(4):15-27.

16.

Needle-free delivery of macromolecules through the skin using controllable jet injectors.

Hogan NC, Taberner AJ, Jones LA, Hunter IW.

Expert Opin Drug Deliv. 2015 May 25:1-12. [Epub ahead of print]

PMID:
26004884
17.

Targeting TRAIL in the treatment of cancer: new developments.

Lim B, Allen JE, Prabhu VV, Talekar MK, Finnberg NK, El-Deiry WS.

Expert Opin Ther Targets. 2015 May 25:1-15. [Epub ahead of print]

PMID:
26004811
18.

Rapid screening of aflatoxin B1 in beer by fluorescence polarization immunoassay.

Beloglazova NV, Eremin SA.

Talanta. 2015 Sep 1;142:170-5. doi: 10.1016/j.talanta.2015.04.027. Epub 2015 Apr 14.

PMID:
26003708
19.

Rapid Assessment of Antibody-Induced Ricin Neutralization by Employing a Novel Functional Cell-Based Assay.

Gal Y, Alcalay R, Sabo T, Noy-Porat T, Epstein E, Kronman C, Mazor O.

J Immunol Methods. 2015 May 20. pii: S0022-1759(15)00162-3. doi: 10.1016/j.jim.2015.05.005. [Epub ahead of print]

PMID:
26003675
20.

Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.

Hallé M, Tribout-Jover P, Lanteigne AM, Boulais J, St-Jean JR, Jodoin R, Girouard MP, Constantin F, Migneault A, Renaud F, Didierlaurent A, Mallett C, Burkhart D, Pilorget A, Palmantier R, Larocque D.

J Immunol Methods. 2015 May 19. pii: S0022-1759(15)00159-3. doi: 10.1016/j.jim.2015.05.002. [Epub ahead of print]

PMID:
26002154
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk